The National Agency for Food and Drug Administration and Control (NAFDAC), pursuant to provisions of the NAFDAC Act, CAP N1 LFN 2004 and the MARKETING (BREAST-MILK SUBSTITUTES) ACT CAP M.5 LFN 2004 and the BMS regulations, in keeping with the WHO International Code of Marketing of Breastmilk Substitutes (BMS) wishes to provide the following clarifications […]
